Amneal Pharmaceuticals, Inc. — Form SCHEDULE 13D/A
Filed August 12, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 18/100
What the filing says
This is an amended Schedule 13D/A filing dated August 12, 2026, by Chirag K. Patel regarding beneficial ownership in Amneal Pharmaceuticals, Inc. (market cap ~$1.7B). The filing document itself does not contain the substantive amendment details, share counts, percentages, or specific changes to beneficial ownership—only metadata is visible in the provided text.
Why this rating
Amendment to beneficial ownership disclosure is routine regulatory filing; no concrete data on holdings or changes provided to assess materiality.
See more from August 12, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.